Showing results (741-750 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|July 21, 2025
A systematic literature review of the association between global brain atrophy and the Expanded Disability Status Scale score in people with multiple sclerosisRobert Zivadinov, Hoa H Le, Alexander Keenan, et al.Therapeutic Advances in Neurological Disorders|October 27, 2025
Ofatumumab in pediatric multiple sclerosis: a case seriesWenlin Wu, Yanping Ran, Chi Hou, et al.Therapeutic Advances in Neurological Disorders|October 13, 2025
Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic reviewMahsa Mohammadi Lapevandani, Elham Bazmi, Shima Jahani, et al.Therapeutic Advances in Neurological Disorders|August 11, 2025
Levodopa-carbidopa intestinal gel for multiple system atrophy with motor fluctuations: a case seriesTatou Iseki, Noriko Nishikawa, Takashi Ogawa, et al.Therapeutic Advances in Neurological Disorders|November 17, 2022
Objective and self-perceived lower limb weakness in Parkinson's diseaseMarlene Alonso-Juarez, Robert Fekete, José Fidel Baizabal-CarvalloTherapeutic Advances in Neurological Disorders|August 5, 2025
Induction of immune tolerance in NMOSD and MOGADJorge Correale, Edgar Carnero ContenttiTherapeutic Advances in Neurological Disorders|August 4, 2025
Neuropsychiatric disorders in Parkinson's diseaseBeatrice Heim, Atbin DjamshidianTherapeutic Advances in Neurological Disorders|August 4, 2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS StudyKlaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.Therapeutic Advances in Neurological Disorders|June 18, 2025
Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic reviewAli Hammed, Almonzer Al-Qiami, Ali Hasan, et al.Therapeutic Advances in Neurological Disorders|June 23, 2025
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomyQing Zhang, XuanXuan Pan, Zhuajin Bi, et al.Pageof 108